Technology & Health: A 21st century Gordian Knot
The Practice of Medicine Faces Two Disruptions Today: 1. Advances in biotechnology enable genes to be edited and immune cells to be harnessed to treat the untreatable and to bring advanced cancer and…
Health Technology Assessment (HTA) is a systematic process that evaluates the social, economic, organizational, and ethical issues of a health intervention or health technology in a comprehensive manner. The primary goal of HTA is to provide decision-makers, such as policymakers, healthcare professionals, and patients, with evidence-based information to make informed choices about the adoption, use, and management of health technologies. HTA considers a wide range of factors, including clinical effectiveness, cost-effectiveness, patient outcomes, and the impact on the healthcare system. It involves the assessment of medical devices, drugs, procedures, and other technologies to determine their value and impact on health outcomes. By synthesizing scientific evidence with economic and ethical considerations, HTA helps prioritize resource allocation in healthcare, ensuring that limited resources are used efficiently and effectively. The process of HTA typically involves several steps, including defining the scope of the assessment, identifying relevant evidence, synthesizing data, and providing recommendations for decision-makers. It promotes transparency and inclusivity by involving various stakeholders, such as patients, clinicians, industry representatives, and policymakers, in the decision-making process.
Speaker lineup for this track will be announced soon.
Browse all speakers →The Practice of Medicine Faces Two Disruptions Today: 1. Advances in biotechnology enable genes to be edited and immune cells to be harnessed to treat the untreatable and to bring advanced cancer and…
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Oral and poster slots for original Health technology assessment work, reviewed by the scientific committee.
Meet public health researchers, educators, and policy leaders from around the world across three days.
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Plenary lectures from leading voices shaping Health technology assessment research and practice.
Attend in person in Singapore or join virtually — same programme, same certificate.
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
The Health technology assessment track is a dedicated stream within IPHC 2027 covering the latest research, innovation, and best practice in Health technology assessment. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Public health researchers, practitioners, epidemiologists, educators, doctoral students, and policy leaders with an interest in Health technology assessment are all welcome — whether presenting or attending.
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Yes. IPHC 2027 is a hybrid conference — attend the Health technology assessment track in person in Singapore or join live online, with on-demand access afterward.
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.